| Primary |
| Arthritis |
18.9% |
| Pain |
10.8% |
| Back Pain |
8.1% |
| Epilepsy |
5.4% |
| Gastrooesophageal Reflux Disease |
5.4% |
| Hypertension |
5.4% |
| Osteoporosis |
5.4% |
| Overdose |
5.4% |
| Rheumatoid Arthritis |
5.4% |
| Adnexa Uteri Pain |
2.7% |
| Affective Disorder |
2.7% |
| Antiinflammatory Therapy |
2.7% |
| Arthralgia |
2.7% |
| Cardiac Disorder |
2.7% |
| Dyspepsia |
2.7% |
| Exostosis |
2.7% |
| Fibromyalgia |
2.7% |
| Hypothyroidism |
2.7% |
| Inflammation |
2.7% |
| Joint Swelling |
2.7% |
|
| Drug Ineffective |
14.7% |
| Wrong Drug Administered |
11.8% |
| Urticaria |
8.8% |
| Dizziness |
5.9% |
| Drug Hypersensitivity |
5.9% |
| Product Substitution Issue |
5.9% |
| Therapeutic Response Unexpected With Drug Substitution |
5.9% |
| Toxic Epidermal Necrolysis |
5.9% |
| Abdominal Pain |
2.9% |
| Coeliac Disease |
2.9% |
| Diarrhoea |
2.9% |
| Drug Screen Positive |
2.9% |
| Gastrointestinal Haemorrhage |
2.9% |
| Haemoglobin Decreased |
2.9% |
| Haemorrhage |
2.9% |
| Heart Rate Increased |
2.9% |
| Hypersensitivity |
2.9% |
| Lip Swelling |
2.9% |
| Medication Error |
2.9% |
| Oral Discomfort |
2.9% |
|
| Secondary |
| Product Used For Unknown Indication |
18.0% |
| Osteoarthritis |
14.8% |
| Arthritis |
8.2% |
| Foetal Exposure During Pregnancy |
8.2% |
| Inflammation |
6.6% |
| Intervertebral Disc Protrusion |
6.6% |
| Ill-defined Disorder |
4.9% |
| Anxiety |
3.3% |
| Back Pain |
3.3% |
| Bone Pain |
3.3% |
| Bursitis |
3.3% |
| Epilepsy |
3.3% |
| Intentional Overdose |
3.3% |
| Multiple Sclerosis |
3.3% |
| Arthralgia |
1.6% |
| Blood Cholesterol Increased |
1.6% |
| Constipation |
1.6% |
| Cough |
1.6% |
| Depression |
1.6% |
| Fibromyalgia |
1.6% |
|
| Drug Hypersensitivity |
12.0% |
| Hypersensitivity |
8.0% |
| Sciatica |
8.0% |
| Somnolence |
8.0% |
| Abdominal Distension |
4.0% |
| Abdominal Pain |
4.0% |
| Drug-induced Liver Injury |
4.0% |
| Eosinophilia |
4.0% |
| Hepatotoxicity |
4.0% |
| Increased Tendency To Bruise |
4.0% |
| Learning Disorder |
4.0% |
| Lip Swelling |
4.0% |
| Medication Error |
4.0% |
| Musculoskeletal Chest Pain |
4.0% |
| Noonan Syndrome |
4.0% |
| Oral Discomfort |
4.0% |
| Rheumatoid Arthritis |
4.0% |
| Vomiting |
4.0% |
| Weight Decreased |
4.0% |
| Weight Increased |
4.0% |
|
| Concomitant |
| Drug Use For Unknown Indication |
18.8% |
| Product Used For Unknown Indication |
15.9% |
| Rheumatoid Arthritis |
12.8% |
| Hypertension |
6.5% |
| Depression |
5.6% |
| Pain |
5.1% |
| Arthritis |
4.0% |
| Gastrooesophageal Reflux Disease |
3.5% |
| Insomnia |
3.2% |
| Psoriatic Arthropathy |
3.2% |
| Diabetes Mellitus |
2.9% |
| Osteoporosis |
2.4% |
| Sleep Disorder |
2.4% |
| Arthralgia |
2.1% |
| Contraception |
2.1% |
| Inflammation |
2.1% |
| Anxiety |
1.9% |
| Bipolar Disorder |
1.9% |
| Blood Cholesterol Increased |
1.9% |
| Ankylosing Spondylitis |
1.8% |
|
| Drug Ineffective |
11.7% |
| Urinary Tract Infection |
7.8% |
| Vomiting |
7.8% |
| Pain |
6.5% |
| Rash |
6.5% |
| Femur Fracture |
5.2% |
| Tardive Dyskinesia |
5.2% |
| Ventricular Tachycardia |
5.2% |
| Weight Increased |
5.2% |
| Injection Site Pain |
3.9% |
| Oedema Peripheral |
3.9% |
| Psoriasis |
3.9% |
| Pyrexia |
3.9% |
| Renal Failure Acute |
3.9% |
| Swelling |
3.9% |
| Torticollis |
3.9% |
| Visual Acuity Reduced |
3.9% |
| Ageusia |
2.6% |
| Arthralgia |
2.6% |
| Balance Disorder |
2.6% |
|
| Interacting |
| Product Used For Unknown Indication |
30.8% |
| Anxiety |
15.4% |
| Musculoskeletal Chest Pain |
15.4% |
| Bursitis |
11.5% |
| Cough |
11.5% |
| Wheezing |
11.5% |
| Fracture Pain |
3.8% |
|
| Increased Tendency To Bruise |
33.3% |
| Musculoskeletal Chest Pain |
33.3% |
| Skin Lesion |
33.3% |
|
